IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

Şevin Turcan(Memorial Sloan Kettering Cancer Center), Daniel Rohle(Memorial Sloan Kettering Cancer Center), Anuj Goenka(Memorial Sloan Kettering Cancer Center), Logan A. Walsh(Memorial Sloan Kettering Cancer Center), Fang Fang(Memorial Sloan Kettering Cancer Center), Emrullah Yilmaz(Memorial Sloan Kettering Cancer Center), Carl Campos(Memorial Sloan Kettering Cancer Center), Armida W. M. Fabius(Memorial Sloan Kettering Cancer Center), Chao Lü(Memorial Sloan Kettering Cancer Center), Patrick S. Ward(University of Pennsylvania), Craig B. Thompson(Memorial Sloan Kettering Cancer Center), Andrew Kaufman(Memorial Sloan Kettering Cancer Center), Olga A. Guryanova(Memorial Sloan Kettering Cancer Center), Ross L. Levine(Memorial Sloan Kettering Cancer Center), Adriana Heguy(Memorial Sloan Kettering Cancer Center), Agnès Viale(Memorial Sloan Kettering Cancer Center), Luc G.T. Morris(Memorial Sloan Kettering Cancer Center), Jason T. Huse(Memorial Sloan Kettering Cancer Center), Ingo K. Mellinghoff(Cornell University), Timothy A. Chan(Cornell University)
Nature
February 14, 2012
Cited by 1,987Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis